Similar efficacy and safety of once-weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
每周一次的度拉糖肽治疗2型糖尿病患者，在年龄≥65岁和<65岁的患者中疗效和安全性相似
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.12687
Boustani, M A; Pittman, I 4th; Yu, M; Thieu, V T; Varnado, O J; Juneja, R
